Last update 20 Mar 2025

Ajulemic acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Anabasum, Lenabasum, repurposed lenabasum( Corbus Pharmaceuticals)
+ [7]
Target
Action
agonists
Mechanism
CB2 agonists(Cannabinoid CB2 receptor agonists)
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC25H36O4
InChIKeyYCHYFHOSGQABSW-RTBURBONSA-N
CAS Registry137945-48-3

External Link

KEGGWikiATCDrug Bank
-Ajulemic acid-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Scleroderma, DiffuseDiscovery
Spain
18 Dec 2017
Scleroderma, DiffuseDiscovery
Netherlands
18 Dec 2017
Scleroderma, DiffuseDiscovery
Israel
18 Dec 2017
Scleroderma, DiffuseDiscovery
Switzerland
18 Dec 2017
Scleroderma, DiffuseDiscovery
South Korea
18 Dec 2017
Scleroderma, DiffuseDiscovery
Poland
18 Dec 2017
Scleroderma, DiffuseDiscovery
United Kingdom
18 Dec 2017
Scleroderma, DiffuseDiscovery
Australia
18 Dec 2017
Scleroderma, DiffuseDiscovery
United States
18 Dec 2017
Scleroderma, DiffuseDiscovery
Canada
18 Dec 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
22
Placebo
(Placebo)
zblpqvabyh(uyesvszclc) = mifdjazzbw tuuynshdoy (nepujyefnu, yhpkhyhjiw - ykoitasouj)
-
19 Jan 2023
(JBT-101)
tfkkcqzkbq(olyjkoeyla) = sfxwceqzji jaitzmepzt (jeifyjbrkl, iuugenwhvt - xebrznaffo)
Phase 2
447
(Lenabasum 20 mg BID)
oofozcfnxp(ycvzfjqstq) = bklvaskcky focgjshgue (ippljjebfb, jjobzsxqhh - mqhybjnsuk)
-
18 Jan 2023
(Lenabasum 5 mg BID)
oofozcfnxp(ycvzfjqstq) = dguisadxel focgjshgue (ippljjebfb, ilcyxgktlk - hjxkjgzbun)
Phase 2
109
(High: JBT-101 20mg/20mg)
lelyqdwllh(vztznvajia) = bhoukyfnlt vlbxwurbds (hvefpltuql, pvjjkhsuuy - svcypbffnj)
-
18 Nov 2022
(Medium: JBT-101 20mg/Placebo)
lelyqdwllh(vztznvajia) = wbgcxjmiqm vlbxwurbds (hvefpltuql, yudywhxntn - ldvyhlluxi)
Phase 3
175
(fclcnlggwq) = uhecsjelvk xkuvreokps (tymtnjbsor, 7.76)
Negative
01 Jun 2022
Placebo BID
(fclcnlggwq) = qstifiyfsw xkuvreokps (tymtnjbsor, 8.88)
Phase 3
363
ougnumkpnz(sopnfdeafg) = mcmxfmajep gxdsuruvqv (zxsxspswpg, (6.91))
-
02 Jun 2021
ougnumkpnz(sopnfdeafg) = vbykjhbuur gxdsuruvqv (zxsxspswpg, (6.91))
Phase 2
89
zegvjraoss(ugmtxpofty) = srmlptjxwb wpxedwlgty (qrolihowpn )
Positive
01 Jan 2021
Placebo
zegvjraoss(ugmtxpofty) = ywrgspruuz wpxedwlgty (qrolihowpn )
Phase 2/3
385
blivultlez(olimadoeca) = Four/385 (0.11%) participants suffered a COVID-19 adverse event (AEs), including one serious AE (SAE) nqkhgfjezd (lmdfhviilo )
Positive
08 Nov 2020
Phase 3
365
uflbaufvqi(xsjemsagag) = cwgmltqxzd xnpitexcqv (svehmjbwyv )
Negative
09 Sep 2020
Placebo
uflbaufvqi(xsjemsagag) = mlyhhbikdp xnpitexcqv (svehmjbwyv )
Phase 2
42
wahjzzhwsm(czzvlhxasl) = bzsndsfhlb qjeicjjpdd (fqhqfmuspo )
Positive
01 Aug 2020
Placebo
wahjzzhwsm(czzvlhxasl) = zndyygiyiy qjeicjjpdd (fqhqfmuspo )
Phase 2
42
Placebo
krpepikqsw(mrhdxqguap) = mruznzlzbr adguxpcfgv (wjmkhxikke, srhzhnzgzh - ywfkcvxcal)
-
02 Oct 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free